VanEck Vectors Pharma ETF (PPH) Stock
Key stats
- Market cap
- $571.01M
- Volume
- Loading
- 52-week high
- $123.53
- 52-week low
- $95.90
Source: third-party data provider, as of November 13, 2026
Recent news

Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
PPH

BMY Stock Drops As Lower-Dose Lung Drug Succeeds In Trial, Higher Dose Misses
BMY Stock Drops As Lower-Dose Lung Drug Succeeds In Trial, Higher Dose Misses
PPH

Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
PPH

Execution of Pharma Tariffs Brings These ETFs Into Focus
Execution of Pharma Tariffs Brings These ETFs Into Focus
PPH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 65.71
- MACD 12/26/9
- 2.42
- EMA 9 of MACD
- 2.04
- MACD histogram
- 0.38
- SMA 50
- $113.39
- Price above SMA 50
- EMA 50
- $114.67
- Price above EMA 50
- SMA 200
- $108.48
- Price above SMA 200
- EMA 200
- $108.95
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
Source: third-party data provider
Latest news

Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
PPH

BMY Stock Drops As Lower-Dose Lung Drug Succeeds In Trial, Higher Dose Misses
BMY Stock Drops As Lower-Dose Lung Drug Succeeds In Trial, Higher Dose Misses
PPH

Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
PPH

Execution of Pharma Tariffs Brings These ETFs Into Focus
Execution of Pharma Tariffs Brings These ETFs Into Focus
PPH

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
PPH

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
PPH

Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long
Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long
PPH

NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip
NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip
PPH

NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen
NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen
PPH

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
PPH
News tone: automated (AI) classification of the article's content, not a price prediction.
About VanEck Vectors Pharma ETF
VanEck Vectors® Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index, which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Fundamentals
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 65.71
- MACD 12/26/9
- 2.42
- EMA 9 of MACD
- 2.04
- MACD histogram
- 0.38
- SMA 50
- $113.39
- Price above SMA 50
- EMA 50
- $114.67
- Price above EMA 50
- SMA 200
- $108.48
- Price above SMA 200
- EMA 200
- $108.95
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -5.7 | +7.8 | ||||||||||
| 2022 | -1.3 | -0.8 | +6.2 | -3.1 | +2.9 | -2.1 | -0.5 | -7.3 | -5.4 | +7.2 | +6.3 | -0.2 |
| 2023 | -0.0 | -3.0 | +2.4 | +1.8 | -4.6 | +4.1 | +3.7 | +2.8 | -2.9 | -4.9 | +4.1 | +3.4 |
| 2024 | +3.2 | +2.9 | +1.1 | -1.9 | +2.8 | +0.8 | +1.5 | +5.3 | -4.1 | -3.4 | -1.4 | -4.3 |
| 2025 | +3.0 | +5.4 | -3.6 | +0.8 | +1.0 | -0.6 | -6.2 | +5.2 | +1.3 | -1.8 | +10.4 | +2.0 |
| 2026 | +3.0 | +3.3 | -5.8 | -2.7 | +2.4 | +6.9 | +2.3 | +4.1 | -4.4 | +10.3 | +2.1 |
Corporate actions
Upcoming
No upcoming corporate actions for PPH




